BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 9:38:18 AM | Browse: 262 | Download: 537
 |
Received |
|
2022-01-29 07:35 |
|
Peer-Review Started |
|
2022-01-29 07:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-12 08:41 |
|
Revised |
|
2022-06-05 21:21 |
|
Second Decision |
|
2022-06-20 03:04 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-06-27 00:04 |
|
Articles in Press |
|
2022-06-27 00:04 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-01 07:29 |
|
Publish the Manuscript Online |
|
2022-07-22 09:38 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Control Study |
| Article Title |
Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Valeria Sanna, Palma Fedele, Giulia Deiana, Maria G Alicicco, Chiara Ninniri, Anna N Santoro, Antonio Pazzola and Alessandro Fancellu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alessandro Fancellu, FACS, MD, PhD, Associate Professor, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 2-Clinica Chirurgica, University of Sassari, V.le San Pietro 43, Sassari 07100, Italy. afancel@uniss.it |
| Key Words |
Edmonton system assessment scale; Adjuvant chemotherapy; Breast cancer; Medical visits; Patient-reported outcomes |
| Core Tip |
Adjuvant chemotherapy is recommended in high-risk breast cancer. We hypothesized that the Edmonton Symptom Assessment Scale (ESAS) can be used to safely reduce the number of medical visits in women with breast cancer undergoing adjuvant chemotherapy. The main result of this case-matched analysis is that ESAS screening may safely reduce the frequency of medical visits in the setting of AC in patients with breast cancer. This finding may have some advantageous implications in oncological practice, especially in the current scenario, where an increase in COVID-19 cases throughout the world has imposed measures for minimising the risk of infection among patients and health care providers. |
| Publish Date |
2022-07-22 09:38 |
| Citation |
Sanna V, Fedele P, Deiana G, Alicicco MG, Ninniri C, Santoro AN, Pazzola A, Fancellu A. Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer. World J Clin Oncol 2022; 13(7): 577-586 |
| URL |
https://www.wjgnet.com/2218-4333/full/v13/i7/577.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v13.i7.577 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
